Technical Analysis for LIPO - Lipella Pharmaceuticals Inc.

Grade Last Price % Change Price Change
C 1.92 -4.00% -0.08
LIPO closed up 8.11 percent on Wednesday, May 31, 2023, on 39 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -4.00%
Crossed Above 50 DMA Bullish -4.00%
MACD Bullish Signal Line Cross Bullish -4.00%
180 Bullish Setup Bullish Swing Setup -4.00%
Above Upper BB Strength -4.00%
Gapped Up Strength -4.00%
Up 3 Days in a Row Strength -4.00%
Upper Bollinger Band Touch Strength -4.00%
20 DMA Resistance Bearish 3.78%
180 Bearish Setup Bearish Swing Setup 3.78%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 26 minutes ago
Down 5% about 3 hours ago
Down 3% about 3 hours ago
Fell Below 50 DMA about 3 hours ago
Down 2 % about 3 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. We believe that this strategy combines many of the cost efficiencies and risk abatements derived from using existing generic drugs with potential patent protections for our proprietary formulations; this strategy allows us to expedite, protect, and monetize our product candidates. Additionally, we maintain a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists, believing that this focus can potentially help reduce the cost, time and risk associated with obtaining marketing approval.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Generic Drug Drug Therapy

Is LIPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.72
52 Week Low 1.69
Average Volume 45,752
200-Day Moving Average 0.00
50-Day Moving Average 1.94
20-Day Moving Average 1.88
10-Day Moving Average 1.89
Average True Range 0.15
RSI (14) 54.75
ADX 9.28
+DI 19.68
-DI 15.80
Chandelier Exit (Long, 3 ATRs) 1.83
Chandelier Exit (Short, 3 ATRs) 2.15
Upper Bollinger Bands 1.98
Lower Bollinger Band 1.78
Percent B (%b) 1.09
BandWidth 10.92
MACD Line -0.02
MACD Signal Line -0.03
MACD Histogram 0.0094
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.19
Resistance 3 (R3) 2.17 2.09 2.16
Resistance 2 (R2) 2.09 2.04 2.10 2.15
Resistance 1 (R1) 2.04 2.01 2.06 2.06 2.14
Pivot Point 1.96 1.96 1.97 1.97 1.96
Support 1 (S1) 1.91 1.91 1.94 1.94 1.86
Support 2 (S2) 1.83 1.88 1.84 1.85
Support 3 (S3) 1.78 1.83 1.84
Support 4 (S4) 1.81